About: Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 2011

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 2011 (uk) article scientifique publié en 2011 (fr) im April 2011 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 2011 (ast) scientific article published on 01 April 2011 (en)
publication date	wds:Q83864125-159445BA-4544-4F84-95CA-AD3D0DB7DB74
publication date	2011-04-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q83864125-2BA2AF47-DC50-4363-BD92-2ADA57CBBFD9
exact match	https://scigraph.springernature.com/pub.10.1007/s12094-011-0654-5
cites work	wds:Q83864125-08C635A9-7FB6-419C-A629-F8134891ECA2 wds:Q83864125-11ABC3BC-CBE9-4A91-8828-3206E005526B wds:Q83864125-1216788F-6C68-418E-80D3-A928D4DA01F7 wds:Q83864125-171D5678-9DB2-4227-AE33-0CC68CE50895 wds:Q83864125-1B0F6EB9-47EF-404D-A310-88177AA84870 wds:Q83864125-1DDC414C-6EE8-4FF7-8212-7C3B958E32D7 wds:Q83864125-2817D711-28F0-4849-B1F4-52C2902E37F0 wds:Q83864125-2DDF58FF-0084-4618-AD05-595E9A073CDB wds:Q83864125-3ABB0DEC-FC8B-41A7-9E2B-E6BDF816D6C1 wds:Q83864125-4289AF97-88DF-4FD7-B8C9-5E91DE92D693 wds:Q83864125-4E00D04B-C218-46CB-944F-6FEB7439941A wds:Q83864125-55E83F52-4717-4845-9D91-A81DE05DC9B3 wds:Q83864125-5F0D6DE7-C147-47E2-9806-E1C72C4CA335 wds:Q83864125-620485D5-477E-4332-9CA8-E73BD323685D wds:Q83864125-6B356309-51C0-461C-AD4B-7B45869A9274 wds:Q83864125-6C349982-65AC-4A58-B908-7910507632D2 wds:Q83864125-7A1D0965-CC12-4699-A307-DF35472588F0 wds:Q83864125-84DC433A-B6C3-4F37-9326-AC72F2D3F233 wds:Q83864125-89685CD7-804F-4F66-9A84-7B186B062A84 wds:Q83864125-8AD8B8C5-B4CA-4D9A-AC09-344CF50515EA wds:Q83864125-982F71DA-ABA8-4A05-A317-64EAE01F8583 wds:Q83864125-9F12D00B-4406-4A41-AB0B-9C0307A63113 wds:Q83864125-A5AC59FD-3ABE-43BA-8678-748CCC622DEF wds:Q83864125-AB3F44F7-0299-4AC0-9ED0-B55F0033FA2F wds:Q83864125-AD77BF88-8904-4BB3-9292-0F95022D2F16 wds:Q83864125-B7BA24F8-5A0E-4B10-A1D0-C73DC23DEC8B wds:Q83864125-BA23578B-3563-431A-934A-EA0A79B8D26D wds:Q83864125-E0E516D0-7A35-45B4-9B8C-346BF1775D0A wds:Q83864125-E5D17A69-5FD8-4950-8E30-82CF6E30BF91 wds:Q83864125-E96EF018-A0B8-4081-8D32-238F619E62AE wds:Q83864125-FEF62B00-3C1B-4BA9-B684-86973B666C25 wds:Q83864125-FFA28791-4B68-4813-8354-12EB350A4432
cites work	Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy One-sample multiple testing procedure for phase II clinical trials Paclitaxel: a review of adverse toxicities and novel delivery strategies. Vinorelbine (Navelbine) in the treatment of breast cancer: a summary. Optimizing the treatment of metastatic breast cancer Cytotoxic agents with activity in breast cancer patients previously exposed to anthracyclines: current status and future prospects Systemic treatment of breast cancer. Two decades of progress Paclitaxel plus vinorelbine: an active regimen in metastatic breast cancer patients with prior anthracycline exposure. All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer. The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potential Vinorelbine--a clinical review Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer A phase II study of carboplatin and vinorelbine as second-line treatment for advanced breast cancer Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancer. UFT plus oral folinic acid with alternating oral and intravenous vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma Effectiveness of 5-fluoruracil and vinorelbine in patients who had received multi-treatments for metastatic breast cancer Guides for adjuvant treatment of colon cancer. TTD Group (Spanish Cooperative Group for Gastrointestinal Tumor Therapy). Anthracycline-induced cardiotoxicity: risk assessment and management. Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I-II clinical trial. [Clinical results of UFT granule of enteric coating (UFT E granule). Osaka UFT E Granule Study Group] Preclinical profile of docetaxel (taxotere): efficacy as a single agent and in combination Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study UFT/leucovorin plus vinorelbine combination for advanced breast cancer Uracil/tegafur plus oral calcium folinate in advanced breast cancer
author name string	wds:Q83864125-09B9225E-D8AB-4BA9-8516-5327D561E7A2 wds:Q83864125-0D1AD63D-1B8D-42BD-BE97-254A98AA6738 wds:Q83864125-15C6DB9B-A5AA-4BDF-B6D8-5A6638BA4DAD wds:Q83864125-326B23CE-85CC-46CD-A385-37ED2EEABFEB wds:Q83864125-5DC297FA-261B-464B-BF13-8B3DE98B2AFA wds:Q83864125-67E44712-D08D-4C87-BE60-C10F97F867D6 wds:Q83864125-7BE2CDCD-9F51-4533-9662-576C40E6C1BB wds:Q83864125-87C145F8-AE2C-4A5F-9935-68D1BE43CAFE wds:Q83864125-9A977C42-AB1E-4664-87AF-BEF7956EFD4A wds:Q83864125-AB32CE07-A551-4E14-9E72-06D7460B8137 wds:Q83864125-AF3113A5-F7AD-4D09-9DE4-A47EB4EC8555 wds:Q83864125-E3E1C602-C9D8-438A-B6AF-5BC80CAA8521
author name string	Manuel Ramos Agustí Barnadas Antonio Antón Nuria Ribelles Mireia Margelí Ana Belén Paules Ana González-Quintás Javier Gayo Jesús Florián Juan Lao María Lomas Spanish Breast Cancer Research Group (GEICAM)
rdfs:label	Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software